Core Scientific’s (CORZ) Buy Rating Reiterated at Canaccord Genuity Group

Canaccord Genuity Group reaffirmed their buy rating on shares of Core Scientific (NASDAQ:CORZ) in a report released on Thursday morning,Benzinga reports. The brokerage currently has a $36.00 price target on the stock.

A number of other brokerages have also recently commented on CORZ. Wolfe Research reissued a “buy” rating on shares of Core Scientific in a research note on Wednesday, July 29th. Freedom Capital raised Core Scientific from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Keefe, Bruyette & Woods raised Core Scientific from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $25.00 to $28.00 in a research report on Thursday, July 30th. Citigroup reiterated a “market outperform” rating on shares of Core Scientific in a report on Wednesday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Core Scientific in a research report on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $31.36.

Core Scientific Price Performance

Shares of CORZ opened at $13.48 on Thursday. Core Scientific has a one year low of $12.31 and a one year high of $30.46. The company has a market cap of $4.33 billion, a PE ratio of -3.05 and a beta of 5.49. The stock has a 50-day moving average of $17.30 and a 200-day moving average of $20.99.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analyst estimates of $144.83 million. Analysts expect that Core Scientific will post -1.36 EPS for the current fiscal year.

Insider Transactions at Core Scientific

In other Core Scientific news, Director Elizabeth Crain purchased 6,000 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The shares were acquired at an average price of $18.33 per share, with a total value of $109,980.00. Following the transaction, the director owned 71,348 shares in the company, valued at $1,307,808.84. The trade was a 9.18% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Eric Weiss purchased 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The stock was acquired at an average cost of $16.33 per share, for a total transaction of $97,980.00. Following the transaction, the director owned 265,262 shares in the company, valued at $4,331,728.46. This represents a 2.31% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders acquired 19,000 shares of company stock valued at $342,290 and sold 100,000 shares valued at $1,881,300. 1.70% of the stock is currently owned by insiders.

Institutional Trading of Core Scientific

Several institutional investors and hedge funds have recently modified their holdings of CORZ. Counterpoint Mutual Funds LLC raised its stake in Core Scientific by 9.3% in the 3rd quarter. Counterpoint Mutual Funds LLC now owns 14,425 shares of the company’s stock valued at $231,000 after acquiring an additional 1,224 shares during the period. Vontobel Holding Ltd. purchased a new stake in Core Scientific during the third quarter valued at about $566,000. State of Alaska Department of Revenue boosted its position in Core Scientific by 36.7% during the third quarter. State of Alaska Department of Revenue now owns 17,493 shares of the company’s stock worth $279,000 after purchasing an additional 4,701 shares during the period. Reliant Investment Management LLC bought a new position in Core Scientific during the third quarter worth about $336,000. Finally, CoreCap Advisors LLC boosted its position in Core Scientific by 205.6% during the third quarter. CoreCap Advisors LLC now owns 4,355 shares of the company’s stock worth $70,000 after purchasing an additional 2,930 shares during the period.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst support remains strong. Cantor Fitzgerald reaffirmed its “Overweight” rating, while Canaccord Genuity and BTIG Research reiterated “Buy” ratings with price targets of $36 and $38, respectively. The broader analyst consensus remains “Moderate Buy,” with an average target of $31.36. Cantor Fitzgerald Reaffirms Overweight Rating for Core Scientific
• Positive Sentiment: Core Scientific’s scheduled third-quarter earnings release on November 5 gives investors a near-term catalyst. Results and management commentary should provide updates on its high-density colocation and artificial-intelligence data-center expansion. Core Scientific Schedules Third Quarter Earnings Release
• Neutral Sentiment: A recent rebound occurred on above-average volume, but Zacks cautioned that current earnings-estimate revisions may not support additional near-term gains. This suggests momentum traders may remain cautious despite the strong analyst targets. Strength Seen in Core Scientific
• Negative Sentiment: Investor risk appetite has weakened for leveraged AI-data-center developers, pressuring Core Scientific alongside Applied Digital and TeraWulf. Concerns about financing costs, valuation, and tenant credit quality—including pressure facing customer CoreWeave—could weigh on the shares. Rotation Out of Debt-Funded AI Builders
• Negative Sentiment: Insider Todd Duchene sold 10,000 shares for approximately $151,200, reducing his position by 0.85%. While the remaining stake is substantial, the transaction adds a modest negative signal. Core Scientific Insider Selling

About Core Scientific

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.